Akebia Therapeutics Inc. (AKBA) dipped -7.81% or -0.7 to $8.26. It is nearly 140699 shares traded, which is 24.3% compare to the average total volume 579038. The market cap of AKBA is $471.31 million. The year to date change is -47.96%. The 52 week price range is from $7.32 to $16.43. Price of AKBA have changed 13.99% during last week. It have changed 4.67% over last month, 14.58% over last 3 months, -8.85% over last 6 months and -40.54% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AKBA is 8.21. It is -0.61% below current price. The stock is at support level of 50-day moving averages. The 200-day Moving Averages for AKBA is 10.19. It is 23.37% above current price. The 52-week High is 16.43. It is 98.91% from the current price. The 52-week Low is 7.32. It is -11.38% from current price.
There are some statistics of AKBA. It is has market cap $471.31 million. The share outstanding is 57.06 million. The average volume is 579038. The percent of top 15 Institution holding is 111.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AKBA is -61.31%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AKBA is -18.21%.